Potential pathogens in multiple sclerosis (MS)

被引:4
作者
Zawada, Mariola [1 ]
机构
[1] Polskiej Akad Nauk, Inst Genet Czlowieka, PL-60479 Poznan, Poland
来源
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ | 2012年 / 66卷
关键词
multiple sclerosis; bacteria; viruses; HERV; vitamin D; TCR; HLA; T-CELL-RECEPTOR; AMYOTROPHIC LATERAL SCLEROSIS; EPSTEIN-BARR-VIRUS; VITAMIN-D; CEREBROSPINAL-FLUID; ENDOGENOUS RETROVIRUSES; ETIOLOGIC SIGNIFICANCE; AUTOIMMUNE-RESPONSE; GENE POLYMORPHISMS; MOLECULAR MIMICRY;
D O I
10.5604/17322693.1015041
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Multiple sclerosis is a neuroimmunological disease in which etiologic agents have not been identified yet. The etiology of MS is complex in its nature and may involve many different agents acting simultaneously or in a cascade manner leading to the development of the disease. The causes of MS development were sought among the factors associated with HLA and TCR genes and human endogenous retroviruses (HERV). Environmental factors such as bacterial, fungal and viral infections as well as potential participation of vitamin D in the pathogenesis of the disease have also been examined. The current state of knowledge concerning potential factors participating in the etiopathogenesis of multiple sclerosis has been reviewed in this paper.
引用
收藏
页码:758 / 770
页数:13
相关论文
共 50 条
[41]   Multiple Sclerosis: Risk Factors and their Interactions [J].
Disanto, Giulio ;
Morahan, Julia M. ;
Ramagopalan, Sreeram V. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (05) :545-555
[42]   Environmental Influencers, MicroRNA, and Multiple Sclerosis [J].
Mohammed, Eiman M. A. .
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2020, 12
[43]   Vitamin D and multiple sclerosis: An update [J].
Pierrot-Deseilligny, Charles ;
Souberbielle, Jean-Claude .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 14 :35-45
[44]   Environmental factors in the development of multiple sclerosis [J].
Michel, L. .
REVUE NEUROLOGIQUE, 2018, 174 (06) :372-377
[45]   Tau in Multiple Sclerosis: A Review of Therapeutic Potential [J].
Hoehne, Carolin ;
Stuve, Olaf ;
Stopschinski, Barbara Elena .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2025, 27 (01)
[46]   The potential of serum neurofilament as biomarker for multiple sclerosis [J].
Bittner, Stefan ;
Oh, Jiwon ;
Havrdova, Eva Kubala ;
Tintore, Mar ;
Zipp, Frauke .
BRAIN, 2021, 144 :2954-2963
[47]   Gut Microbiome as Potential Therapeutics in Multiple Sclerosis [J].
Zhu, Wen ;
Dykstra, Kiersten ;
Zhang, Lili ;
Xia, Zongqi .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2021, 23 (11)
[48]   The Potential for EBV Vaccines to Prevent Multiple Sclerosis [J].
Maple, Peter A. ;
Ascherio, Alberto ;
Cohen, Jeffrey I. ;
Cutter, Gary ;
Giovannoni, Gavin ;
Shannon-Lowe, Claire ;
Tanasescu, Radu ;
Gran, Bruno .
FRONTIERS IN NEUROLOGY, 2022, 13
[49]   Risk factors for multiple sclerosis and associations with anti-EBV antibody titers [J].
Mouhieddine, Tarek H. ;
Darwish, Hata ;
Fawaz, Lama ;
Yamout, Bassem ;
Tannim, Hani ;
Khoury, Samia J. .
CLINICAL IMMUNOLOGY, 2015, 158 (01) :59-66
[50]   Monocyte-derived dendritic cells: a potential target for therapy in multiple sclerosis (MS) [J].
Duddy, ME ;
Dickson, G ;
Hawkins, SA ;
Armstrong, MA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (02) :280-287